Green Thumb Industries (GTBIF) Enterprise Value (2018 - 2026)
Green Thumb Industries' (GTBIF) quarterly Enterprise Value came in at -$340.5 million in Q1 2026, down 61.06% YoY from -$874.3 million in Q1 2025, and down 26.53% on a QoQ basis from -$269.1 million in Q4 2025.
Green Thumb Industries (GTBIF) Enterprise Value (2018 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 9 years of Enterprise Value data on file, last reported at -$340.5 million in Q1 2026.
- Quarterly Enterprise Value fell 61.06% year-over-year to -$340.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$340.5 million (down 61.06% YoY) and the FY2025 annual result came in at -$269.1 million, down 56.55% from the prior year.
- Enterprise Value retreated to -$340.5 million in Q1 2026, from -$269.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$136.3 million in Q3 2023 to a low of -$340.5 million in Q1 2026.
- A 5-year average of -$191.3 million and a median of -$174.4 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 59.18% — and 2026, when it slumped 61.06%.
- Tracing GTBIF's Enterprise Value over 5 years: stood at -$177.2 million in 2022, then grew by 8.98% to -$161.3 million in 2023, then dropped by 6.59% to -$171.9 million in 2024, then plunged by 56.55% to -$269.1 million in 2025, then declined by 26.53% to -$340.5 million in 2026.
- The last three Enterprise Value figures came in at -$340.5 million (Q1 2026), -$269.1 million (Q4 2025), and -$219.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | -281.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -281.41 Mn |
| Mar 31, 2026 | -340.47 Mn |
| Dec 31, 2025 | -269.09 Mn |
| Sep 30, 2025 | -219.69 Mn |
| Jun 30, 2025 | -170.72 Mn |
| Mar 31, 2025 | -211.40 Mn |
| Dec 31, 2024 | -171.88 Mn |
| Sep 30, 2024 | -173.75 Mn |
| Jun 30, 2024 | -196.05 Mn |
| Mar 31, 2024 | -223.81 Mn |
| Dec 31, 2023 | -161.26 Mn |
| Sep 30, 2023 | -136.28 Mn |
| Jun 30, 2023 | -148.49 Mn |
| Mar 31, 2023 | -185.01 Mn |
| Dec 31, 2022 | -177.17 Mn |
| Sep 30, 2022 | -146.98 Mn |
| Jun 30, 2022 | -144.96 Mn |
| Mar 31, 2022 | -174.39 Mn |
| Dec 31, 2021 | -232.06 Mn |
| Sep 30, 2021 | -285.90 Mn |